EUVIMEDEUVIMED entdecken
Crossref

BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate

Selami Demirci, Jing Zeng, Rahul Palchaudhuri, Chuanfeng Wu, Diana M Abraham, Taha B Hayal, Khaled Essawi, My Anh Nguyen, Ulana Stasula, Rebecca Chu, Alexis Leonard, Shaina N Porter und 29 weitere

Cell Stem Cell · 2025

DOI: 10.1016/j.stem.2024.10.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2025. Verfasst von Selami Demirci und 40 weiteren Autor:innen. Beteiligte Einrichtung: National Heart, Lung, and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of He…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Fetal Hemoglobin, Leukocyte Common Antigens, Immunoconjugates. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Foundation for the National Institutes of Health, National Heart Lung and Blood Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Editing the +58 region of the BCL11A erythroid enhancer has shown promise in treating β-globin disorders. To address variations in fetal hemoglobin (HbF) response, we investigated editing both +58 and +55 enhancers. Rhesus macaques transplanted with edited hematopoietic stem/progenitor cells (HSPCs) following busulfan conditioning exhibited durable, high-level (∼90%) editing frequencies post transplantation with sustained HbF reactivation over 4 years, without hematological perturbations. HbF levels were further boosted by stress erythropoiesis or hydroxyurea. Bone marrow analysis revealed that gene edits were predominantly programmed deletions, programmed inversions, and short indels, each disrupting the enhancer core TGN7-9WGATAR half E-box/GATA binding motifs. Nonprogrammed long deletions were disfavored in engrafting cells. CD45 antibody-drug conjugate (ADC) conditioning achieved comparable engraftment and HbF reactivation, whereas lentiviral vector tracking showed polyclonal reconstitution with dynamics similar to animals conditioned with total body irradiation (TBI) or busulfan. Joining CD45-ADC conditioning with combined enhancer editing presents an effective strategy for β-hemoglobinopathies, enabling durable HbF reactivation without chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsFetal HemoglobinLeukocyte Common AntigensImmunoconjugatesHematopoietic Stem Cell TransplantationGene EditingEnhancer Elements, GeneticRepressor ProteinsAnimalsMacaca mulattaTransplantation ConditioningBusulfanHumans

Stichwörter der Autor:innen

CRISPR-Cas9HSC transplantationantibody conditioningbusulfanfetal hemoglobinhydroxyureasickle cell diseasetherapeutic gene editingβ-globin disordersγ-globin

Substanzen

Fetal HemoglobinLeukocyte Common AntigensImmunoconjugatesRepressor ProteinsBusulfanBCL11A protein, human

Autor:innen und Institutionen

  • National Heart, Lung, and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20814, USA. Electronic address: selami.demirc…
  • Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Broad Institute of MIT and Harvard, Department of Pediatrics, Har…
  • Magenta Therapeutics, Cambridge, MA 02139, USA.
  • Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20814, USA.
  • Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Gizan 45142, Saudi Arabia.
  • National Heart, Lung, and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20814, USA.

Förderung

  • Foundation for the National Institutes of Health
  • National Heart Lung and Blood Institute
  • National Institutes of Health
  • Harvard Stem Cell Institute
  • Division of Intramural Research
  • Doris Duke Charitable Foundation

Zitieren

APA

Demirci, S., Zeng, J., Palchaudhuri, R., Wu, C., Abraham, D. M., Hayal, T. B., Essawi, K., Nguyen, M. A., Stasula, U., Chu, R., Leonard, A., Porter, S. N., Khan, M. B. N., Hinojosa, G., Uchida, N., Hong, S., Lazzarotto, C. R., Neri, N. R., da Silva, L. F., …, & Tisdale, J. F. (2025). BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate. Cell Stem Cell. https://doi.org/10.1016/j.stem.2024.10.014

Vancouver

Demirci S, Zeng J, Palchaudhuri R, Wu C, Abraham DM, Hayal TB, et al. BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate. Cell Stem Cell. 2025. doi:10.1016/j.stem.2024.10.014

BibTeX
@article{Demirci2025,
  author = {Demirci, Selami and Zeng, Jing and Palchaudhuri, Rahul and Wu, Chuanfeng and Abraham, Diana M and Hayal, Taha B and Essawi, Khaled and Nguyen, My Anh and Stasula, Ulana and Chu, Rebecca and Leonard, Alexis and Porter, Shaina N and Khan, Muhammad Behroz Naeem and Hinojosa, Gabriela and Uchida, Naoya and Hong, Sogun and Lazzarotto, Cicera R and Neri, Nola R and da Silva, Lucas Ferreira and Pellin, Danilo and Verma, Archana and Lanieri, Leanne and Bhat, Anjali and Hammond, Katelyn and Tate, Tiffany and Maitland, Stacy A and Sheikhsaran, Fatemeh and Bonifacino, Aylin C and Krouse, Allen E and Linde, Nathaniel S and Engels, Theresa and Golomb, Justin and Tsai, Shengdar Q and Pruett-Miller, Shondra M and Scadden, David T and Dunbar, Cynthia E and Wolfe, Scot A and Donahue, Robert E and Olson, Lisa M and Bauer, Daniel E and Tisdale, John F},
  title = {BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate},
  journal = {Cell Stem Cell},
  year = {2025},
  doi = {10.1016/j.stem.2024.10.014}
}
Kostenlos starten →